Medicxi

Medicxi is a leading European life sciences venture capital and private equity firm focused on investing in innovative biotech, pharma, and healthcare startups. It was founded in 2016 by the former Index Ventures life sciences team. The company manages multiple funds and has supported numerous successful exits through acquisitions of its portfolio companies by major pharmaceutical firms such as Eli Lilly, Gilead, and Incyte. Recent activity includes merging six dermatology-focused biotechs into Alys Pharmaceuticals with $100M seed funding. Its portfolio includes public companies like Centessa Pharmaceuticals and Molecular Partners. Investors include GlaxoSmithKline, Johnson & Johnson Innovation – JJDC Inc., Novartis, and Verily/Alphabet. Offices are located in London (UK), St. Helier (Jersey), and Geneva (Switzerland).